Kathleen Dm's Colleagues at QED Therapeutics
Kathleen Dm's Contact Details
HQ
650-231-4088
650-231-4088
Location
Buffalo,New York,United States
Buffalo,New York,United States
Company
QED Therapeutics
QED Therapeutics
Kathleen Dm's Company Details
QED Therapeutics, a subsidiary of BridgeBio Pharma, is a biotechnology company focused on precision medicine for FGFR-driven disorders. Our lead candidate is infigratinib, a best-in-class FGFR kinase inhibitor that has shown meaningful clinical activity in chemotherapy-refractory cholangiocarcinoma with FGFR2 fusions. QED is also evaluating infigratinib in preclinical studies for the treatment of achondroplasia. We plan to develop infigratinib in additional FGFR-driven tumor types and rare disorders.
Frequently Asked Questions about Kathleen Dm
Kathleen Dm currently works for QED Therapeutics.
Kathleen Dm's role at QED Therapeutics is Sr. Director, MSL Team.
Kathleen Dm's email address is ***@qedtx.com. To view Kathleen Dm's full email address, please signup to ConnectPlex.
Kathleen Dm works in the Research industry.
Kathleen Dm's colleagues at QED Therapeutics are Jack Winnike, Anne Lee, Keith Steward, Roo Vold, Joyce Velez, Richard Jones, Cortney Galasso and others.
Kathleen Dm's phone number is 650-231-4088